Granulomatosis with polyangiitis (GPA), which used to be known as Wegener's granulomatosis, is a rare condition where the blood vessels become inflamed. Typically it affects older or middle-aged ...

Granulomatosis with polyangiitis (GPA), previously known as Wegener’s granulomatosis, is a rare and life-threatening disorder that restricts the blood flow to several organs, including the lungs ...

Granulomatosis with polyangiitis (GPA), known as Wegener’s granulomatosis until 2011, is a rare and potentially serious condition that causes inflammation of the small blood vessels and capillaries.

Wegener's granulomatosis (newly renamed granulomatosis with polyangiitis [WG/GPA]) is a granulomatous autoimmune inflammatory disorder of unknown etiology that is associated with anti-neutrophil ...

Baltimore, MD - The large negative trial of etanercept (Enbrel, Amgen) in Wegener's granulomatosis, reported at the 2004 American College of Rheumatology meeting, has now been published in the New ...

The majority of patients with Wegener's granulomatosis have disease flares after conventional medications are tapered. There is no consistently safe, effective treatment for the maintenance of ...

Wegener's disease, also known as Wegener's granulomatosis, belongs to a group of diseases characterized by blood vessel inflammation (vasculitis). Most commonly, it affects the sinuses ...

These results in association with the MRI and biopsy findings led to the diagnosis of Wegener's granulomatosis of the orbit. Further paediatric evaluation failed to show any systemic or renal ...

This page lists all known medications that could potentially lead to 'Wegener's granulomatosis' as a side effect. It's important to note that mild side effects are quite common with medications.

What is Wegener's granulomatosis or granulomatosis with polyangiitis? Granulomatosis with polyangiitis (GPA), which used to be known as Wegener's granulomatosis, is a rare condition where the ...

The treatment of Wegener's granulomatosis, one of the most common forms of systemic vasculitis, has changed substantially over the past two decades. The principal aims of therapy are to control ...